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Molecular analysis of archival tumor specimens has
accelerated the discovery of clinically useful biomarkers.
RNA-seq of RNA extracted from formalin fixed, paraf-
fin-embedded (FFPE) specimens, a potentially valuable
source of biomarkers, is hampered by the presence of
highly abundant ribosomal RNA (rRNA), which is diffi-
cult to remove due to extensive RNA degradation. Here
we report RNA-seq results from human FFPE samples.
RNA was extracted from estrogen receptor positive
(ER+) and negative (ER-) FFPE breast tumors 7-8 years
after fixation and embedding. Sequencing libraries were
prepared using a proprietary protocol with known
strand direction. On average, 14 million reads were
obtained from each lane of the Illumina GAII. After
employing a proprietary rRNA depletion method, 18S
and 28S rRNA are reduced to less than 5% of total
mapped reads. Approximately 25 000 unique Ref-seq
gene transcripts were detected in each library, demon-
strating detection of most rare and intermediate tran-
scripts as well as abundantly expressed transcripts. The
relative abundance of the estrogen receptor gene ESR1
and co-expressed transcripts in the ESR1+ and ESR1-
tumors correlated with expression differences measured
by qPCR.
Directional analysis indicated that 95% of the reads
mapped to known genes had the correct direction,
whereas remaining 5% with antisense direction, which
possibly serve as regulatory functions. Among the
uniquely mapped reads, ~ 25% were within known
exons, 41% in introns, and 34% in intergenic regions.
‘Valleys’ and ‘hills’ were commonly observed across the
three mapped regions. A proprietary region analysis
method was developed to identify any region (not lim-
ited to known Ref-seqs) exhibiting differential expres-
sion. Using this method, we identified 34 regions that
were highly differentially expressed between the ESR1+
and ESR1- tumor specimens. These regions represent
exons, introns and intergenic areas. Our findings were
confirmed by qPCR.
These preliminary studies demonstrate the feasibility
of using RNA-seq with FFPE tumor specimens. We
anticipate that RNA-seq will provide a new perspective
about transcriptional changes that underlie the pheno-
types of individual tumors.
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